Brady Priest - Jul 18, 2022 Form 3 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role
CEO of Home Care
Signature
/s/ Joseph R. Martin, as Attorney-in-Fact
Stock symbol
CLOV
Transactions as of
Jul 18, 2022
Transactions value $
$0
Form type
3
Date filed
7/19/2022, 04:52 PM
Next filing
Jul 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CLOV Stock Options (right to buy) Jul 18, 2022 Class B Common Stock 79.3K $1.26 Direct F1, F2
holding CLOV Stock Options (right to buy) Jul 18, 2022 Class B Common Stock 362K $1.67 Direct F2, F3
holding CLOV Stock Options (right to buy) Jul 18, 2022 Class B Common Stock 60.3K $3.66 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received in connection with an August 10, 2016, grant covering 229,349 shares of the Company's Class B common stock. 150,000 shares subject to this grant were exercised and sold prior to the date hereof, and the remaining 79,349 shares subject to the grant are currently vested and exercisable.
F2 The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation.
F3 Received in connection with a September 13, 2017, grant covering 362,252 shares of the Company's Class B common stock. 100% of the shares subject to this grant are currently vested and exercisable.
F4 Received in connection with a June 29, 2020, grant covering 103,302 shares of the Company's Class B common stock. 43,085 shares subject to this grant were canceled prior to the date hereof, and the remaining 60,318 shares subject to the grant are currently vested and exercisable.

Remarks:

Exhibit List: Exhibit 24-Power of Attorney